Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Circio Holding ASA

Market Cap 180.92Cr 19Cr 16Cr 15Cr 14Cr 27Cr 1.8TCr 27Cr 178.84Cr 70Cr 881.29Cr 71Cr 70Cr 3.05TCr P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 181.15Cr 19Cr 16Cr 15Cr 14Cr 27Cr 1.8TCr 27Cr 179.07Cr 70Cr 882.38Cr 72Cr 70Cr 3.05TCr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
69.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+3.40%
1 week-5.35%
Current month-15.56%
1 month-23.77%
3 months+43.40%
6 months+515.88%
Current year+552.92%
1 week 7.02
Extreme 7.02
8.29
1 month 7.02
Extreme 7.02
11.56
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
20.4
5 years 0.48
Extreme 0.48
274.5
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/21/30Fiscal year

Chief Executive Officer

1,20,000 0.1386%
19/21/19Buy

Director

21,299 0.0246%
03/20/03Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+3.40%-5.35%+1,042.86%-59.40% 18Cr
+3.23%+2.93%+61.50%+113.87% 5.45TCr
+0.04%+5.05%+43.44%+36.75% 4.39TCr
+2.73%+6.31%-12.75%-16.70% 2.26TCr
+5.95%+6.44%-2.48%+383.89% 2.07TCr
-0.53%-0.27%+12.68%-37.07% 1.58TCr
+5.27%+1.87%+13.67%-38.00% 1.48TCr
-2.54%-0.57%+26.42%+176.03% 1.31TCr
-5.17%+4.13%+13.12% - 1.27TCr
-7.73%+6.58%+79.67%+104.65% 1.16TCr
Average +1.15%-1.03%+127.81%+73.78% 2.1TCr
Weighted average by Cap. +1.39%+0.17%+33.10%+89.97%

Financials

2024 2025
Net sales - -
Net income 5.75Cr 60.5L 52.19L 47.98L 45.16L 84.87L 57Cr 85.58L 5.69Cr 2.21Cr 28Cr 2.27Cr 2.22Cr 97Cr -4.59Cr -48.28L -41.65L -38.29L -36.04L -67.73L -46Cr -68.3L -4.54Cr -1.77Cr -22Cr -1.81Cr -1.77Cr -77Cr
Net Debt -10L -1L -88.19T -81.08T -76.31T -1L -96.47L -1L -10L -4L -47.35L -4L -4L -1.64Cr 22.45L 2L 2L 2L 2L 3L 2.23Cr 3L 22.19L 9L 1.09Cr 9L 9L 3.78Cr
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
17/26/17 7.600 kr +3.40% 99,46,023
16/26/16 7.350 kr -9.59% 82,48,773
15/26/15 8.130 kr -0.37% 22,88,009
12/26/12 8.160 kr +9.09% 76,24,359
11/26/11 7.480 kr -6.85% 77,89,340

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!